Assessing molecular mechanisms underlying novel cardiomyopathy risk loci in survivors of childhood cancer

Project: Research project

Project Details


Dr Burridge will provide hiPSC lines, hiPSC-cardiomyocytes and isogenic cell lines to St. Jude shortly after they are generated in sufficient quantities for further propagation and use. Dr. Burridge will return the research results to St. Jude under a separate Data Transfer and Use Agreement.
Effective start/end date6/11/209/30/23


  • St. Jude Children's Research Hospital (AGMT 04/13/21)


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.